Report updated Apr 19, 2026
Pyrls
For the app is primarily designed for pharmacists, pharmacy students, and clinical practitioners requiring rapid access to medication data.
Overview · Full Intel report in progress
Pyrls is an established medical app that is available. With a 4.8/5 rating from 222 reviews, it shows polarized user reception.
What is Pyrls?
Current Momentum
v1.8 · 2mo ago
ActiveLast updated 74d ago. 5 versions tracked.
Competition
Rivals identification in progress
7-Day Rank Pulse 🇺🇸
MedicalNo ranking data
Rating Pulse 🇺🇸
What makes this app unique?
What Does It Look Like?
What Are The Key Features?
Provides essential information on drug naming, indications, and pharmacology.
Offers counseling points and clinical pearls regarding safety, monitoring, and place in therapy.
Includes a library of reference tables, figures, and charts to assist in understanding complex medical topics.
How much does it cost?
Who Built It?
Cosmas Health
Providing visual-first drug reference tools and clinical pearls to help healthcare professionals access practical medication data quickly.
Portfolio
3
Apps
What other apps does Cosmas Health make?
Explore the full Cosmas Health report
Portfolio breakdown, audience, momentum, and every app published by Cosmas Health.
Analysis in progress, available soon
What do users think recently?
Analysis in progress, available soon
View the full user-sentiment analysis
Mood gauge, ratings & review-volume history, every praise / complaint / request, and sentiment over time.
Analysis in progress, available soon
What is the competitive landscape for Pyrls?
Where is it available?
Localized markets (1)
How's The Medical Market?
How does it evolve in the Medical market?
Rank progression
88 active rankings tracked — 30-day window
Strategic analysis coming soon
SWOT, key takeaways & outlook
The outtake for Pyrls
Key Takeaways
Pyrls focuses on simplifying clinical drug information through a highly visual, chart-based interface tailored for pharmacy education and practice.
Where Is It Heading?
Trend analysis
Available very soon